Literature DB >> 26176941

PCNA tightens its hold on the nucleus.

Lynne S Cox1.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26176941      PMCID: PMC4613660          DOI: 10.1080/15384101.2015.1064699

Source DB:  PubMed          Journal:  Cell Cycle        ISSN: 1551-4005            Impact factor:   4.534


× No keyword cloud information.
The sliding clamp protein PCNA is a key controller of multiple processes in DNA and chromatin metabolism, regulating replication, repair and chromatin assembly through interaction with a huge number of partner proteins (). In many of these transactions, the partners bind via a conserved PCNA-interacting peptide or PIP, first identified in CDKN1/p21. Sequential and competitive binding of these PIPs within the interdomain connector loop (IDCL) of PCNA provides a means to ensure ordered reactions.
Figure 1.

PCNA's many partners. Interactions with PCNA (structure from PDB 1axc) can be through classical PIP motif (Qxx[L/I/M]xx[F/Y][F/Y], (pale boxes)) binding to the interdomain connector loop in PCNA or via an APIM motif ([K/R]VF[I/V]K) (dark boxes). The newly identified PCNA partners Maf1, RNF7 and SetD3 (black arrows) contribute to transcription, ubiquitination and chromatin regulation.

PCNA's many partners. Interactions with PCNA (structure from PDB 1axc) can be through classical PIP motif (Qxx[L/I/M]xx[F/Y][F/Y], (pale boxes)) binding to the interdomain connector loop in PCNA or via an APIM motif ([K/R]VF[I/V]K) (dark boxes). The newly identified PCNA partners Maf1, RNF7 and SetD3 (black arrows) contribute to transcription, ubiquitination and chromatin regulation. Adding to the roll call of PCNA partners, Cooper et al. have now employed bimolecular fluorescence complementation (BiFC) screening to look for proteins that bind to PCNA ‘bait’ in normally proliferating human cells; unlike in vitro interaction studies and heterologous yeast 2 hybrid screens, BiFC screening in cycling human cells provides a platform for physiologically relevant protein interaction discovery. Combining FACS sorting with the speed and depth of reads possible with next generation sequencing also allows the scale-up of this type of screen for identification of drug targets. Notably, this screen identified novel PCNA partners that do not necessarily interact through the canonical PIP (though a number of the expected partners were also detected). Interactions were not universal across all cells – perhaps because the initial screen did not enrich for S phase cells – nor particularly robust (the signal was lost on detergent treatment), while use of a skeletal muscle cDNA library probably influenced the range of partner proteins identified – SetD3, for instance, is important in muscle differentiation. Nevertheless, this screen is powerful and interactions with RNF7, Maf1 and SetD3 were validated by a range of direct assays. So what might these novel partners tell us about how PCNA acts in cells? SetD3 is a histone H3 lysine methyltransferase that adjusts the histone code to promote a transcription-competent chromatin conformation. Perhaps interaction here simply adds to PCNA's repertoire in assisting copying of the histone code immediately after replication fork passage, as postulated from its association with Caf1 and Asf1. While SetD3 does not have every residue of a classical PIP, the motif QKGLSVTF may be adequate for association with PCNA's IDCL. Notably the aromatic residues play a critical role in binding affinity with tyrosine (e.g. p21 PIP = QTSMTDFY) conferring much tighter PCNA binding than phenylalanine (e.g., Fen1 PIP= QGRLDDFF). Maf1 and RNF7 are small proteins without identifiable PIPs; but lack of a PIP does not prevent other partners such as RF-C from binding PCNA with high affinity, nor proteins that bind through the alternative APIM motif. Regulation of the cell cycle through PIP-dependent degradation of key protein such as p27, Cdt1 and – most recently - Cdc6 provides yet another critical role for PCNA. Its interaction with RNF-7, an essential Skp1-cullin/cdc53 F box ubiquitin ligase is therefore not unexpected, and may help to ensure that replication occurs once and only once per cell cycle. Given that MCM disassembly from terminating replication forks requires MCM7 ubiquitination by an as yet unidentified cullin-family protein, PCNA at a terminating replication fork might also provide a platform for recruitment of an ubiquitin ligase at the right time and place to regulate replisome disassembly. Integration of nutritional status and stress signals is essential to ensure appropriate cell cycle progression; increasing evidence supports a cytosolic role for PCNA in signaling, with APIM peptide-containing proteins implicated in cell cycle control and damage signaling. Hence the finding that Maf1, a transcriptional repressor, binds PCNA might provide a further link between cytosolic signaling (in this case via mTORC, which targets Maf1) and transcriptional responses. PIP or no PIP, PCNA partners play a huge role in the cell and PCNA is turning out to be one of the major hubs coordinating cellular metabolism.
  7 in total

1.  Polyubiquitylation drives replisome disassembly at the termination of DNA replication.

Authors:  Sara Priego Moreno; Rachael Bailey; Nicholas Campion; Suzanne Herron; Agnieszka Gambus
Journal:  Science       Date:  2014-10-24       Impact factor: 47.728

2.  PIP-box-mediated degradation prohibits re-accumulation of Cdc6 during S phase.

Authors:  Linda Clijsters; Rob Wolthuis
Journal:  J Cell Sci       Date:  2014-01-16       Impact factor: 5.285

3.  Who binds wins: Competition for PCNA rings out cell-cycle changes.

Authors:  L S Cox
Journal:  Trends Cell Biol       Date:  1997-12       Impact factor: 20.808

4.  Sequential switching of binding partners on PCNA during in vitro Okazaki fragment maturation.

Authors:  Daniel Dovrat; Joseph L Stodola; Peter M J Burgers; Amir Aharoni
Journal:  Proc Natl Acad Sci U S A       Date:  2014-09-16       Impact factor: 11.205

5.  A small peptide inhibitor of DNA replication defines the site of interaction between the cyclin-dependent kinase inhibitor p21WAF1 and proliferating cell nuclear antigen.

Authors:  E Warbrick; D P Lane; D M Glover; L S Cox
Journal:  Curr Biol       Date:  1995-03-01       Impact factor: 10.834

6.  A fluorescent bimolecular complementation screen reveals MAF1, RNF7 and SETD3 as PCNA-associated proteins in human cells.

Authors:  Simon E Cooper; Elsie Hodimont; Catherine M Green
Journal:  Cell Cycle       Date:  2015-06-01       Impact factor: 4.534

7.  Identification of a novel, widespread, and functionally important PCNA-binding motif.

Authors:  Karin M Gilljam; Emadoldin Feyzi; Per A Aas; Mirta M L Sousa; Rebekka Müller; Cathrine B Vågbø; Tara C Catterall; Nina B Liabakk; Geir Slupphaug; Finn Drabløs; Hans E Krokan; Marit Otterlei
Journal:  J Cell Biol       Date:  2009-09-07       Impact factor: 10.539

  7 in total
  1 in total

1.  miR-30b inhibits autophagy to alleviate hepatic ischemia-reperfusion injury via decreasing the Atg12-Atg5 conjugate.

Authors:  Shi-Peng Li; Jin-Dan He; Zhen Wang; Yao Yu; Shu-Yu Fu; Hai-Ming Zhang; Jian-Jun Zhang; Zhong-Yang Shen
Journal:  World J Gastroenterol       Date:  2016-05-14       Impact factor: 5.742

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.